TIS 0.00% 0.0¢ tissue therapies limited

TIS - EMA position may be reasonable, page-4

  1. 347 Posts.
    Also, if what you say is correct it means that new TRIALS (on patients) are not required. Just new Tests to determine the stability of this ingredient.
    The above interpretation is consistent with the announcement today - which doesn't refer to trial data.
    If new tests need to be done the timeline may be quite different from clinical trials.
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.